Biosimulation Market Size Is Anticipated To Reach USD 6.83 Billion by 2028

 Biosimulation Market Growth & Trends

The global biosimulation market size is anticipated to reach USD 6.83 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.9% from 2021 to 2028. The key factors fueling the market growth include the increasing incidence of chronic diseases, increase in healthcare digitization, and usage of biosimulation solutions in clinical trials and research.

The need for drug discovery and development amidst the prevalence of acute and chronic diseases has resulted in an increase in the allocation of funds for R&D activities, which has propelled the adoption of biosimulation solutions. In addition, a high drug attrition rate leads to an increase in the cost of clinical trials, which is expected to drive the clinical urgency to incorporate in silico biology approach. This approach significantly reduces the probability of drug failure by predicting biological interactions, thereby reducing the overall costs.

Arise in drug relapse rates, drug resistance cases, and limited availability of drugs to treat diseases such as AIDS have led to high clinical urgency for the adoption of biosimulation in applications, such as drug development and drug discovery.

The COVID-19 pandemic also had a significant impact on the market. Simulations Plus, for instance, launched the StrategiesPlus COVID-19 ACT Program in March 2020 for speeding consulting assistance to any organization involved in the COVID-19 research. As of November 2020, the company declared that its business was not materially adversely affected. However, the continuing spread of COVID-19 and the measures taken by the governments of the affected countries are likely to disrupt the supply chain and adversely impact its business and financial performance.

Surging demand for biosimulation software and services can also be attributed to their higher cost-efficiency. Biosimulation solutions enable cost-effective prediction of toxicity, adverse reactions, and efficacy of investigational drugs during early stages of product development, thus limiting the probability of drug relapse and adverse events at later stages.

Request a free sample copy or view report summary: Biosimulation Market Report

Biosimulation Market Report Highlights

• In terms of product, software dominated the market in 2020. This can be attributed to the availability of a wide range of application-specific software that suits research requirements. Furthermore, biosimulation software is being used in clinical trials and it also eases modeling and target drug identification
• By application, the drug development segment accounted for the largest share in 2020
• Based on end use, pharmaceutical and biotechnology companies dominated the market in 2020 due to increasing strategic initiatives
• North America grabbed the largest share in 2020. The presence of a favorable reimbursement framework (especially post the implementation of the Affordable Care Act) and sophisticated healthcare infrastructure is expected to drive the North American market over the forecast period
• Asia Pacific is expected to grow significantly during the forecast period owing to the increase in the number of CROs, growth in spending on healthcare IT, and rapidly evolving healthcare infrastructure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biosimulation-market

Biosimulation Market Segmentation

Grand View Research has segmented the global biosimulation market on the basis of product, application, end use, and region:

Biosimulation Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Services
  • In-house Services
  • Contract Services

Biosimulation Application Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Development
• Drug Discovery
• Others

Biosimulation End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Pharmaceutical & Biotechnology Companies
• CROs
• Regulatory Authorities
• Academic Research Institutions

Biosimulation Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

List of Key Players of Biosimulation Market

• Certara
• DassaultSystemes
• Advanced Chemistry Development
• Simulation Plus
• Schrodinger, Inc.
• Chemical Computing Group ULC
• PhysiomicsPlc
• Rosa & Co. LLC
• BioSimulation Consulting Inc.
• Genedata AG
• Instem Group of Companies
• PPD, Inc. (Evidera)
• Insilico Biotechnology AG
• Immunetrics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.